Regulation of human retinal blood flow by endothelin-1

Experimental Eye Research

Volumn 76, Issue 5, 2003, Pages 633-640

  Polak, Kaija ^a   Luksch, Alexandra ^a   Frank, Barbara ^a   Jandrasits, Kerstin ^a   Polska, Elzbieta ^a   Schmetterer, Leopold ^a,b  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Endothelin; Endothelin receptors; Human; Retinal blood flow; Retinal vessel diameter

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; PLACEBO; CYCLO(TRP ASP PRO VAL LEU); CYCLO(TRP-ASP-PRO-VAL-LEU); CYCLOPEPTIDE; ENDOTHELIN RECEPTOR;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL DIAMETER; CONTROLLED STUDY; DRUG EFFECT; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; RETINA BLOOD FLOW; VASOCONSTRICTION; BLOOD FLOW; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; LASER DOPPLER FLOWMETRY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RETINA BLOOD VESSEL;

ADULT; BLOOD PRESSURE; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ENDOTHELIN-1; HEMODYNAMIC PROCESSES; HUMANS; LASER-DOPPLER FLOWMETRY; MALE; PEPTIDES, CYCLIC; RECEPTORS, ENDOTHELIN; REGIONAL BLOOD FLOW; RETINAL VESSELS;

EID: 0037403058     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4835(02)00312-3     Document Type: Article

References (47)

1. Cellini M., Possati G.L., Profazio V., Sbrocca M., Caramazza N., Caramazza R. Color Doppler imaging and plasma levels of endothelin-1 in low-tension glaucoma. Acta. Ophthalmol. Scand. 224:1997;11-13.
2. Chakravarthy U., Gardiner T., Anderson P., Archer D.B., Trimble E.R. The effect of endothelin-1 on the retinal microvascular pericyte. Microvasc. Res. 43:1992;241-254.
3. Chakravarthy U., Hayes R.G., Stitt A.W., Douglas A. Endothelin expression in ocular tissues of diabetic and insulin-treated rats. Invest. Ophthalmol. Vis. Sci. 38:1997;2144-2151.
4. Cioffi G.A., Orgül S., Onda E., Bacon D.R., van Buskirk E.M. An in vivo model of chronic optic nerve ischemia: the dose-dependent effects of endothelin-1 on the optic nerve microvasculature. Curr. Eye Res. 14:1995;1147-1153.
5. Cioffi G.A., Sullivan P. The effect of ischemia on the primate optic nerve. Br. J. Ophthalmol. 9:1999;S34-S36.
6. Dallinger S., Dorner G.T., Wenzel R., Graselli U., Findl O., Eichler H.G., Wolzt M., Schmetterer L. Endothelin-1 contributes to hyperoxia-induced vasoconstriction in the human retina. Invest. Ophthalmol. Vis. Sci. 41:2000;864-869.
7. De Juan J.A., Moya F.J., Ripodas A., Bernal R., Fernandez-Cruz A., Fernandez-Durango R. Changes in the density and localization of endothelin receptors in the early stages of rat diabetic retinopathy and the effect of insulin treatment. Diabetologia. 43:2000;773-785.
8. Deng D., Evans T., Mukherjee K., Downey D., Chakrabarti S. Diabetes-induced vascular dysfunction in the retina: role of endothelins. Diabetologia. 42:1999;1228-1234.
9. Gass A., Flammer J., Linder L., Romerio S.C., Gasser P., Haefeli W.E. Inverse correlation between endothelin-1 induced peripheral microvascular vasoconstriction and blood pressure in glaucoma. Graefes Arch. Clin. Exp. Ophthalmol. 235:1997;634-638.
10. Granstam E., Wang L., Bill A. Ocular effects of endothelin-1 in the cat. Curr. Eye Res. 11:1992;325-332.
11. Haefliger I.O., Dettmann E., Liu R., Meyer P., Prünte C., Messerli J., Flammer J. Potential role of nitric oxide and endothelin in the pathogenesis of glaucoma. Surv. Ophthalmol. 43:1999;S51-S58.
12. Haefliger I.O., Flammer J., Lüscher T.F. Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery. Invest. Ophthalmol. Vis. Sci. 33:1992;2340-2343.
13. Haefliger I.O., Flammer J., Lüscher T.F. Heterogeneity of endothelium-dependent regulation in ophthalmic and ciliary arteries. Invest. Ophthalmol. Vis. Sci. 34:1993;1722-1730.
14. Hopfner R.L., Gopalakrishnan V. Endothelin: emerging role in diabetic vascular complications. Diabetologia. 42:1999;1383-1394.
15. Iannaccone A., Letizia C., Pazzaglia S., Vingolo E.M., Clemente G., Pannarale M.R. Plasma endothelin-1 concentrations in patients with retinal vein occlusions. Br. J. Ophthalmol. 82:1998;498-503.
16. Kaiser H.J., Flammer J., Wenk M., Lüscher T. Endothelin-1 plasma levels in normal tension glaucoma: abnormal response to postural changes. Graefes Arch. Clin. Exp. Ophthalmol. 233:1995;484-488.
17. Kiel J.W. Endothelin modulation of choroidal blood flow in the rabbit. Exp. Eye Res. 71:1999;543-550.
18. MacCumber M.W., D'Anna S.A. Endothelin receptor binding subtypes in the human retina and choroid. Arch. Ophthalmol. 112:1995;1231-1235.
19. Meyer P., Flammer J., Lüscher T.F. Endothelium-dependent regulation of the ophthalmic microcirculation in the perfused porcine eye: role of nitric oxide and endothelins. Invest. Ophthalmol. Vis. Sci. 23:1993;3614-3621.
20. Nishimura K., Riva C.E., Harino S., Reinach P., Cranstoun S.D., Mita S. Effect of endothelin-1 on optic nerve head blood flow in cats. J. Ocul. Pharmacol. Ther. 12:1996;75-83.
21. Oku H., Sugiyama T., Kojima S., Watanabe T., Azuma I. Experimental optic cup enlargement caused by endothelin-1 induced chronic optic nerve head ischemia. Surv. Ophthalmol. 44:1999;S74-S84.
22. Orgül S., Cioffi G.A., Bacon D.R., van Buskirk E.M. An endothelin-1 induced model of optic nerve ischemia in the rabbit. Curr. Eye Res. 5:1996;135-139.
23. Orgül S., Cioffi G.A., Wilson D.J., Bacon D.R., van Buskirk E.M. An endothelin-1 induced model of optic nerve ischemia in the rabbit. Invest. Ophthalmol. Vis. Sci. 37:1996;1860-1869.
24. Pernow J., Franco-Cereceda A., Matran R., Lundberg J.M. Effect of endothelin-1 on regional vascular resistances in the pig. J. Cardiovasc. Pharmacol. 13:1989;S205-S206.
25. Polak K., Petternel V., Luksch A., Krohn J., Findl O., Polska E., Schmetterer L. Effect of endothelin and BQ123 on ocular blood flow parameters in healthy subjects. Invest. Ophthalmol. Vis. Sci. 42:2001;2949-2956.
26. Riva C.E., Grunwald J.E., Sinclair S.H., O'Keefe K. Fundus camera based LDV. Appl. Opt. 20:1981;117-120.
27. Riva C.E., Grundwald J.E., Sinclair S.H., Petrig B.L. Blood velocity and volumetric flow rate in human retinal vessels. Invest. Ophthamol. Vis. Sci. 26:1985;1124-1132.
28. Rolinski B., Geier S.A., Sadri I., Klauss V., Bogner J.R., Ehrenreich H., Goebel F.D. Endothelin-1 immunoreactivity in plasma is elevated in HIV-1 infected patients with retinal microangiopathic syndrome. Clin. Investig. 72:1994;288-293.
29. Rubanyi G.M., Polokoff M.A. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Rev. 46:1994;325-415.
30. Schiffrin E.L., Touyz R.M. Vascular biology of endothelin. J. Cardiovasc. Pharmacol. 32:1998;S2-S13.
31. Schmetterer L., Dallinger S., Bobr B., Selenko N., Eichler H.G., Wolzt M. Systemic and renal effects of an ET(A) receptor subtype-specific antagonist in healthy subjects. Br. J. Pharmacol. 124:1998;930-934.
32. Schmetterer L., Findl O., Strenn K., Jilma B., Graselli U., Eichler H.G., Wolzt M. Effects of endothelin-1 (ET-1) on ocular hemodynamics. Curr. Eye Res. 16:1997;687-692.
33. Schmetterer L., Wolzt M. Ocular blood flow and associated functional deviations in diabetic retinopathy. Diabetologia. 42:1999;387-405.
34. Schmitz-Spanke S., Schipke J.D. Potential role of endothelin-1 and endothelin antagonists in cardiovascular disease. Basic Res. Cardiol. 95:2000;290-298.
35. Soper C.P., Latif A.B., Bending M.R. Amelioration of hepatorenal syndrome with selective endothelin-A antagonist. Lancet. 347:1996;1842-1843.
36. Stitt A.W., Chakravarthy U., Gardiner T.A., Archer D.B. Endothelin-like immunoreactivity and receptor binding in the choroid and retina. Curr. Eye Res. 15:1996;111-117.
37. Strenn K., Matulla B., Wolzt M., Findl O., Bekes M.C., Lamsfuss U., Graselli U., Rainer G., Menapace R., Eichler H.G., Schmetterer L. Reversal of enodthelin-1 induced ocular hemodynamic effects by low-dose nifedipine in humans. Clin. Pharmacol. Ther. 63:1998;54-63.
38. Sugiyama T., Moriya S., Oku H., Azuma I. Association of endothelin-1 with normal tension glaucoma: clinical and fundamental studies. Surv. Ophthalmol. 39:1995;S49-S56.
39. Takagi C., Bursell S.E., Lin Y.W., Takagi H., Duh E., Jiang Z., Clermont A.C., King G.L. Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1. Invest. Ophthalmol. Vis. Sci. 37:1996;2504-2518.
40. Takase H., Moreau P., Luscher T.F. Endothelin receptor subtypes in small arteries. Studies with FR139317 and bosentan. Hypertension. 25:1995;739-743.
41. Taniguchi T., Okada K., Haque M.S., Sugiyama K., Kitazawa Y. Effects of endothelin-1 on intraocular pressure and aqueous humor dynamics in the rabbit eye. Curr. Eye Res. 13:1994;461-464.
42. Vierhapper H., Wagner O., Nowotny P., Waldhäusl W. Effect of endothelin-1 in man. Circulation. 81:1990;1415-1418.
43. Vilser W., Riemer T., Bräuer-Burchardt C., Münch K., Senff I., Kleen W., Bachmann K., Pietscher G.E., Lang G.E., Lang G.K. Retinal vessel analyzer (RVA) - a new measuring system for examination of local and temporal vessel behaviour. Invest. Ophthalmol. Vis. Sci. 38:1997;S1050.
44. Wiederholt M., Bielka S., Schweig F., Lutjen Decroll E., Lepple-Wienhuis A. Regulation of outflow rate and resistance in the perfused anterior segment of the bovine eye. Exp. Eye Res. 61:1995;233-234.
45. Withrington P.G., de Nucci G., Vane N.R. Endothelin-1 causes vasoconstriction and vasodilation in the blood perfused liver of the dog. J. Cardiovasc. Pharmacol. 13:1989;S209-S210.
46. Wollensak G., Schaefer H.E., Ihling C. An immunohistochemical study of endothelin-1 in the human eye. Curr. Eye Res. 17:1998;541-545.
47. Yoo K., Tschudi M., Lüscher T.F. Endothelium-dependent regulation of vascular tone on the porcine ophthalmic artery. Invest. Ophthalmol. Vis. Sci. 32:1991;1791-1798.